Skip to main content
. 2015 May 4;4(2):139–151. doi: 10.5492/wjccm.v4.i2.139

Table 10.

Drug dosing considerations in adult patients receiving extracorporeal membrane oxygenation

Drug dosing recommendations for an adult on ECMO are unlikely to be evidenced-based
Data from neonatal case reports, case series or studies may not apply to adults
Data from one drug may not be applicable to another even from the same class
Drug regimen recommendations in critical care guidelines may not apply to patients on ECMO
Organ dysfunction apart from the lung and heart complicate interpretation of literature
The contribution of distinct physicochemical properties of drugs to sequestration is unclear
Hydrophilicity or lipophilicity appear to be important factors affecting pharmacokinetics
The therapeutic actions of drugs are not consistently predictable by pharmacokinetics
The design and properties of the equipment change over time with implications for dosing
The priming solution such as blood or blood-derived products may affect dosing

ECMO: Extracorporeal membrane oxygenation.